Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Consideration of Potential Conflicts in <i>U.S. v. Clemens</i>

By Ellen C. Brotman and Michael B. Hayes
February 28, 2011

Snow is melting, seed catalogs are arriving, and eyes have turned to Spring Training. Some baseball fans are also turning their attention to the U.S. District Court for the District of Columbia to follow the recent developments in U.S. v. Clemens, 1:10-cr-00223-RBW. The indictment, filed in Aug. 2010, charges player Clemens with six counts: three counts of making false statements to Congress, two counts of perjury and one count of obstruction of Congress. (The trial is scheduled for July 2011.)

The charges arise out of testimony that Clemens gave before Congress on Feb. 8 and Feb. 13, 2008, concerning the use of performance enhancing drugs (PEDs) in Major League Baseball. Clemens flatly denied ever using PEDs. It appears that recently retired Yankees pitching ace Andy Pettitte, a former teammate of Clemens', remembers things differently. Prosecutors anticipate that Pettitte, a government witness, will testify that Clemens admitted using PEDs to him some years ago, according to court documents in U.S. v. Clemens.

This premium content is locked for LJN Newsletters subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

CLE Shouldn't Be the Only Mandatory Training for Attorneys Image

Each stage of an attorney's career offers opportunities for a curriculum that addresses both the individual's and the firm's need to drive success.

A defendant in a patent infringement suit may, during discovery and prior to a <i>Markman</i> hearing, compel the plaintiff to produce claim charts, claim constructions, and element-by-element infringement analyses.